Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research

Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials

(2013) Vibeke Strand et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study

(2013) Daniel J Wallace et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

Abatacept for lupus nephritis: Alternative definitions of complete response support conflicting conclusions

(2012) David Wofsy et al.   ARTHRITIS AND RHEUMATISM

Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures

(2012) Meenakshi Jolly et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 years

(2012) Z Touma et al.   LUPUS

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months

(2012) Z. Touma et al.   RHEUMATOLOGY

The BILAG-2004 systems tally—a novel way of representing the BILAG-2004 index scores longitudinally

(2012) Chee-Seng Yee et al.   RHEUMATOLOGY

Development of the CLASI as a Tool to Measure Disease Severity and Responsiveness to Therapy in Cutaneous Lupus Erythematosus

(2011) Rachel Klein et al.   ARCHIVES OF DERMATOLOGY

Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor

(2011) Derrick J. Todd et al.   ARTHRITIS AND RHEUMATISM

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50: A Reliable Index for Measuring Improvement in Disease Activity

(2011) ZAHI TOUMA et al.   JOURNAL OF RHEUMATOLOGY

Generic Versus Disease-specific Measures of Health-related Quality of Life in Systemic Lupus Erythematosus

(2011) V. STRAND et al.   JOURNAL OF RHEUMATOLOGY

SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation

(2011) Z Touma et al.   LUPUS

Measures of adult systemic lupus erythematosus: Updated Version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questi

(2011) Juanita Romero-Diaz et al.   ARTHRITIS CARE & RESEARCH

An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA

(2010) D. A. Isenberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Development and Initial Validation of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50

(2010) Z. TOUMA et al.   JOURNAL OF RHEUMATOLOGY

International consensus for a definition of disease flare in lupus

(2010) N Ruperto et al.   LUPUS

Numerical scoring for the BILAG-2004 index

(2010) Chee-Seng Yee et al.   RHEUMATOLOGY

Novel evidence-based systemic lupus erythematosus responder index

(2009) Richard A. Furie et al.   ARTHRITIS AND RHEUMATISM

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

SLEDAI-2K for a 30-day window

(2009) Z. Touma et al.   LUPUS

The BILAG-2004 index is sensitive to change for assessment of SLE disease activity

(2009) Chee-Seng Yee et al.   RHEUMATOLOGY

Systemic lupus international collaborating clinics renal activity/response exercise: Development of a renal activity score and renal response index

(2008) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM